Back to search
Invasive Group A Beta-Haemolytic Streptococcal Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Group A Beta-Haemolytic Streptococcal Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Group A Beta-Haemolytic Streptococcal Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Streptococcus pyogenes, commonly referred to as Group A Streptococcus (GAS), has the ability to induce a diverse range of illnesses. In several European countr…
This study aims to emulate a hypothetical target pragmatic multi-center, non-blinded trial of adult inpatients in the PINC AITM dataset with B-lactam treated cu…
Introduction Since 2022 there are reports of a rapid increase in invasive group A streptococcal infections (iGAS) in children in some but not all European count…
The goal of this study is to gain important knowledge on the pathogenesis and prognostic factors in severe invasive group A streptococcal (GAS) infections, as w…